Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury

David Hsu, Masayuki Fukata, Yasmin G. Hernandez, John P. Sotolongo, Tyralee Goo, Junsuke Maki, Lory A. Hayes, Ryan C. Ungaro, Anli Chen, Keith J. Breglio, Ruliang Xu, Maria T Abreu

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Epiregulin (EPI) and amphiregulin (AR) are epidermal growth factor receptor (EGFR) ligands implicated in mucosal repair and tumorigenesis. We have shown that Toll-like receptor 4 (TLR4) induces intestinal epithelial cell (IEC) proliferation by activating EGFR through AR expression. We examined whether TLR4 differentially regulates expression of EGFR ligands in response to mucosal injury. The human IEC line SW480 was examined expression of EGFR ligands, EGFR phosphorylation, and proliferation in response to lipopolysaccharide (LPS). Small-interfering RNA (siRNA) was used to block TLR4. Neutralizing antibodies to EGFR ligands were used to examine inhibition of LPS-dependent EGFR activation. Acute colitis and recovery were examined in the mice given 2.5% dextran sodium sulfate (DSS). Colonic secretion of EPI and AR was analyzed by enzyme-linked immunosorbent assay. LPS selectively induces EPI and AR but not other EGFR ligands. LPS induced early EPI mRNA expression between 30 min and 24 h. The neutralizing antibodies to EPI and AR prevented activation of EGFR by LPS. LPS induces IEC proliferation (200%, P0.01) in 24 h but blocking EPI and AR significantly decreased proliferation. In vivo, mucosal EPI and AR expression are significantly decreased in TLR4 / mice (P0.02) compared to wild-type mice during acute colitis. EPI and AR exhibit different kinetics in response to mucosal damage: EPI expression is upregulated acutely at day 7 of DSS, but falls during recovery at day 14. By contrast, a sustained upregulation of AR expression is seen during mucosal injury and repair. We show that TLR4 regulates EPI and AR expression and that both these EGFR ligands are necessary for optimal proliferation of IEC. The diverse kinetics of EPI and AR expression suggest that they function in distinct roles with respect to acute injury vs repair. Our results highlight the role of bacterial sensing for IEC homeostasis and may lead to targeted therapy for mucosal healing and prevention of tumorigenesis.

Original languageEnglish
Pages (from-to)1295-1305
Number of pages11
JournalLaboratory Investigation
Volume90
Issue number9
DOIs
StatePublished - Sep 1 2010

Fingerprint

Toll-Like Receptor 4
Epidermal Growth Factor
Epidermal Growth Factor Receptor
Intercellular Signaling Peptides and Proteins
Wounds and Injuries
Lipopolysaccharides
Ligands
Epithelial Cells
Dextran Sulfate
Colitis
Neutralizing Antibodies
Carcinogenesis
Epiregulin
Amphiregulin
Cell Proliferation
Small Interfering RNA
Homeostasis
Up-Regulation
Enzyme-Linked Immunosorbent Assay
Phosphorylation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology

Cite this

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. / Hsu, David; Fukata, Masayuki; Hernandez, Yasmin G.; Sotolongo, John P.; Goo, Tyralee; Maki, Junsuke; Hayes, Lory A.; Ungaro, Ryan C.; Chen, Anli; Breglio, Keith J.; Xu, Ruliang; Abreu, Maria T.

In: Laboratory Investigation, Vol. 90, No. 9, 01.09.2010, p. 1295-1305.

Research output: Contribution to journalArticle

Hsu, D, Fukata, M, Hernandez, YG, Sotolongo, JP, Goo, T, Maki, J, Hayes, LA, Ungaro, RC, Chen, A, Breglio, KJ, Xu, R & Abreu, MT 2010, 'Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury', Laboratory Investigation, vol. 90, no. 9, pp. 1295-1305. https://doi.org/10.1038/labinvest.2010.100
Hsu, David ; Fukata, Masayuki ; Hernandez, Yasmin G. ; Sotolongo, John P. ; Goo, Tyralee ; Maki, Junsuke ; Hayes, Lory A. ; Ungaro, Ryan C. ; Chen, Anli ; Breglio, Keith J. ; Xu, Ruliang ; Abreu, Maria T. / Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. In: Laboratory Investigation. 2010 ; Vol. 90, No. 9. pp. 1295-1305.
@article{2c48e06cae334d0982fc2d45f825a865,
title = "Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury",
abstract = "Epiregulin (EPI) and amphiregulin (AR) are epidermal growth factor receptor (EGFR) ligands implicated in mucosal repair and tumorigenesis. We have shown that Toll-like receptor 4 (TLR4) induces intestinal epithelial cell (IEC) proliferation by activating EGFR through AR expression. We examined whether TLR4 differentially regulates expression of EGFR ligands in response to mucosal injury. The human IEC line SW480 was examined expression of EGFR ligands, EGFR phosphorylation, and proliferation in response to lipopolysaccharide (LPS). Small-interfering RNA (siRNA) was used to block TLR4. Neutralizing antibodies to EGFR ligands were used to examine inhibition of LPS-dependent EGFR activation. Acute colitis and recovery were examined in the mice given 2.5{\%} dextran sodium sulfate (DSS). Colonic secretion of EPI and AR was analyzed by enzyme-linked immunosorbent assay. LPS selectively induces EPI and AR but not other EGFR ligands. LPS induced early EPI mRNA expression between 30 min and 24 h. The neutralizing antibodies to EPI and AR prevented activation of EGFR by LPS. LPS induces IEC proliferation (200{\%}, P0.01) in 24 h but blocking EPI and AR significantly decreased proliferation. In vivo, mucosal EPI and AR expression are significantly decreased in TLR4 / mice (P0.02) compared to wild-type mice during acute colitis. EPI and AR exhibit different kinetics in response to mucosal damage: EPI expression is upregulated acutely at day 7 of DSS, but falls during recovery at day 14. By contrast, a sustained upregulation of AR expression is seen during mucosal injury and repair. We show that TLR4 regulates EPI and AR expression and that both these EGFR ligands are necessary for optimal proliferation of IEC. The diverse kinetics of EPI and AR expression suggest that they function in distinct roles with respect to acute injury vs repair. Our results highlight the role of bacterial sensing for IEC homeostasis and may lead to targeted therapy for mucosal healing and prevention of tumorigenesis.",
author = "David Hsu and Masayuki Fukata and Hernandez, {Yasmin G.} and Sotolongo, {John P.} and Tyralee Goo and Junsuke Maki and Hayes, {Lory A.} and Ungaro, {Ryan C.} and Anli Chen and Breglio, {Keith J.} and Ruliang Xu and Abreu, {Maria T}",
year = "2010",
month = "9",
day = "1",
doi = "10.1038/labinvest.2010.100",
language = "English",
volume = "90",
pages = "1295--1305",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury

AU - Hsu, David

AU - Fukata, Masayuki

AU - Hernandez, Yasmin G.

AU - Sotolongo, John P.

AU - Goo, Tyralee

AU - Maki, Junsuke

AU - Hayes, Lory A.

AU - Ungaro, Ryan C.

AU - Chen, Anli

AU - Breglio, Keith J.

AU - Xu, Ruliang

AU - Abreu, Maria T

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Epiregulin (EPI) and amphiregulin (AR) are epidermal growth factor receptor (EGFR) ligands implicated in mucosal repair and tumorigenesis. We have shown that Toll-like receptor 4 (TLR4) induces intestinal epithelial cell (IEC) proliferation by activating EGFR through AR expression. We examined whether TLR4 differentially regulates expression of EGFR ligands in response to mucosal injury. The human IEC line SW480 was examined expression of EGFR ligands, EGFR phosphorylation, and proliferation in response to lipopolysaccharide (LPS). Small-interfering RNA (siRNA) was used to block TLR4. Neutralizing antibodies to EGFR ligands were used to examine inhibition of LPS-dependent EGFR activation. Acute colitis and recovery were examined in the mice given 2.5% dextran sodium sulfate (DSS). Colonic secretion of EPI and AR was analyzed by enzyme-linked immunosorbent assay. LPS selectively induces EPI and AR but not other EGFR ligands. LPS induced early EPI mRNA expression between 30 min and 24 h. The neutralizing antibodies to EPI and AR prevented activation of EGFR by LPS. LPS induces IEC proliferation (200%, P0.01) in 24 h but blocking EPI and AR significantly decreased proliferation. In vivo, mucosal EPI and AR expression are significantly decreased in TLR4 / mice (P0.02) compared to wild-type mice during acute colitis. EPI and AR exhibit different kinetics in response to mucosal damage: EPI expression is upregulated acutely at day 7 of DSS, but falls during recovery at day 14. By contrast, a sustained upregulation of AR expression is seen during mucosal injury and repair. We show that TLR4 regulates EPI and AR expression and that both these EGFR ligands are necessary for optimal proliferation of IEC. The diverse kinetics of EPI and AR expression suggest that they function in distinct roles with respect to acute injury vs repair. Our results highlight the role of bacterial sensing for IEC homeostasis and may lead to targeted therapy for mucosal healing and prevention of tumorigenesis.

AB - Epiregulin (EPI) and amphiregulin (AR) are epidermal growth factor receptor (EGFR) ligands implicated in mucosal repair and tumorigenesis. We have shown that Toll-like receptor 4 (TLR4) induces intestinal epithelial cell (IEC) proliferation by activating EGFR through AR expression. We examined whether TLR4 differentially regulates expression of EGFR ligands in response to mucosal injury. The human IEC line SW480 was examined expression of EGFR ligands, EGFR phosphorylation, and proliferation in response to lipopolysaccharide (LPS). Small-interfering RNA (siRNA) was used to block TLR4. Neutralizing antibodies to EGFR ligands were used to examine inhibition of LPS-dependent EGFR activation. Acute colitis and recovery were examined in the mice given 2.5% dextran sodium sulfate (DSS). Colonic secretion of EPI and AR was analyzed by enzyme-linked immunosorbent assay. LPS selectively induces EPI and AR but not other EGFR ligands. LPS induced early EPI mRNA expression between 30 min and 24 h. The neutralizing antibodies to EPI and AR prevented activation of EGFR by LPS. LPS induces IEC proliferation (200%, P0.01) in 24 h but blocking EPI and AR significantly decreased proliferation. In vivo, mucosal EPI and AR expression are significantly decreased in TLR4 / mice (P0.02) compared to wild-type mice during acute colitis. EPI and AR exhibit different kinetics in response to mucosal damage: EPI expression is upregulated acutely at day 7 of DSS, but falls during recovery at day 14. By contrast, a sustained upregulation of AR expression is seen during mucosal injury and repair. We show that TLR4 regulates EPI and AR expression and that both these EGFR ligands are necessary for optimal proliferation of IEC. The diverse kinetics of EPI and AR expression suggest that they function in distinct roles with respect to acute injury vs repair. Our results highlight the role of bacterial sensing for IEC homeostasis and may lead to targeted therapy for mucosal healing and prevention of tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=77956245973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956245973&partnerID=8YFLogxK

U2 - 10.1038/labinvest.2010.100

DO - 10.1038/labinvest.2010.100

M3 - Article

VL - 90

SP - 1295

EP - 1305

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 9

ER -